GSK plc ADR buy Guggenheim
Start price
04.03.24
/
50%
€38.80
Target price
04.03.25
-
Performance (%)
-7.22%
End price
05.03.25
€36.00
Summary
This prediction ended on 05.03.25 with a price of €36.00. With a performance of -7.22%, the BUY prediction for GSK plc ADR by Guggenheim closed slightly in the red. Dividends of €1.45 are taken into consideration when calculating the performance. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| GSK plc ADR | 1.770% | 1.770% | 41.104% |
| iShares Core DAX® | 1.001% | 4.831% | 8.149% |
| iShares Nasdaq 100 | 2.702% | -1.720% | 26.924% |
| iShares Nikkei 225® | 3.519% | -3.506% | 48.064% |
| iShares S&P 500 | 1.766% | 1.273% | 23.577% |
Comments by Guggenheim for this prediction
In the thread GSK plc ADR diskutieren
GSK plc (NYSE: GSK) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating.
Ratings data for GSK provided by MarketBeat
In the thread Trading GSK plc ADR
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten

